Bayer Aktiengesellschaft (FRA:BAYN)
27.25
0.00 (0.02%)
Last updated: Sep 26, 2025, 5:44 PM CET
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 10.74B EUR in the quarter ending June 30, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 46.17B, down -1.99% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.17B
Revenue Growth
-1.99%
P/S Ratio
0.58
Revenue / Employee
515.59K
Employees
91,864
Market Cap
26.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Rheinmetall AG | 10.67B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Bayer Aktiengesellschaft News
- 1 day ago - Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada - Business Wire
- 1 day ago - Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025 - Business Wire
- 1 day ago - Focus: Parkinson's disease at forefront of Bayer bet on cell and gene therapies - Reuters
- 3 days ago - Shilpa Medicare shares jump over 4% as EMA grants nod for Rivaroxaban Orodispersible Films - Business Upturn
- 4 days ago - Bayer CEO: overhaul is leading to pharma pipeline boost - Reuters
- 4 days ago - Bayer moves Parkinson's cell therapy into Phase III trial - Reuters
- 4 days ago - Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson's Disease - Business Wire
- 8 days ago - Irelands pharma sector is world class, but why dont we have a Novo Nordisk to take our success to the next level? - Independent Ireland